Cargando…

Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics

SIMPLE SUMMARY: Precise and personalized radiology and nuclear medicine are in need of a new, biological contrast media and radionuclide. This inventive strategy is progressing due to the developing of contrast agents and radionuclides based on exosomes. The compatibility of exosomes with existing i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenc, Tomasz, Chrzanowski, Julian, Olejarz, Wioletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698051/ https://www.ncbi.nlm.nih.gov/pubmed/33207614 http://dx.doi.org/10.3390/cancers12113386

Ejemplares similares

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy
por: Lorenc, Tomasz, et al.
Publicado: (2020)

Brownian Motion Influence on AFM Exosomes’ Size Measurements
por: Życieńska, Katarzyna, et al.
Publicado: (2022)

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
por: Yang, Dongbin, et al.
Publicado: (2020)

Exosome secretion and cellular response of DU145 and PC3 after exposure to alpha radiation
por: Pszczółkowska, Beata, et al.
Publicado: (2022)

Clinical Perspectives of Theranostics
por: Okamoto, Shozo, et al.
Publicado: (2021)

Exosomes in Cancer: Circulating Immune-Related Biomarkers
por: Głuszko, Alicja, et al.
Publicado: (2019)

Exosomal Chaperones and miRNAs in Gliomagenesis: State-of-Art and Theranostics Perspectives
por: Caruso Bavisotto, Celeste, et al.
Publicado: (2018)

Exosome Theranostics: Biology and Translational Medicine
por: He, Chuanjiang, et al.
Publicado: (2018)

Exosome-Based Theranostics for Liver Diseases
por: Luo, Nianan, et al.
Publicado: (2022)

Exosomes and ultrasound: The future of theranostic applications
por: Sridharan, Badrinathan, et al.
Publicado: (2023)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
por: Debnath, Sashi, et al.
Publicado: (2022)

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics
por: Fu, Lei, et al.
Publicado: (2016)

Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research
por: Ailuno, Giorgia, et al.
Publicado: (2020)

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
por: He, Aojie, et al.
Publicado: (2023)

Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon
por: Toyama, Yoshitaka, et al.
Publicado: (2021)

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
por: Manners, Natasha, et al.
Publicado: (2022)

Exosomes: Biological Pharmaceutical Nanovectors for Theranostics
por: Thomas, Shindu C., et al.
Publicado: (2022)

Decoding of exosome heterogeneity for cancer theranostics
por: Dhar, Rajib, et al.
Publicado: (2023)

Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
por: Dhupal, Madhusmita, et al.
Publicado: (2020)

Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers
por: Gulati, Richa, et al.
Publicado: (2022)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
por: Xu, Xiao, et al.
Publicado: (2023)

Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment
por: Sadowski, Karol, et al.
Publicado: (2022)

Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue
por: Li, Qicheng, et al.
Publicado: (2023)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

PSMA Theranostics: Current Landscape and Future Outlook
por: Zhang, Hanbo, et al.
Publicado: (2021)

Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease
por: Tatullo, Marco, et al.
Publicado: (2020)

Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world()
por: Limaye, Nimita
Publicado: (2013)

Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications
por: Longo, Dario Livio, et al.
Publicado: (2017)

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
por: Wu, Zijun, et al.
Publicado: (2021)

Contrast Media: Are There Differences in Nephrotoxicity among Contrast Media?
por: Solomon, Richard
Publicado: (2014)

Theranostics with photodynamic therapy for personalized medicine: to see and to treat
por: Wang, Youchao, et al.
Publicado: (2023)

Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions
por: Dominiak, Agnieszka, et al.
Publicado: (2020)

Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis
por: Yi, Xiaomei, et al.
Publicado: (2022)

PSMA Theranostics: Current Status and Future Directions
por: Rahbar, Kambiz, et al.
Publicado: (2018)

Milk exosomes: Nature's abundant nanoplatform for theranostic applications
por: Adriano, Benilde, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_likfhcv0jc0oh1q2s6j5ltesft